HEALTHSCMP CHINA
China’s first AI-powered cancer vaccine production line set to launch in Beijing
China is developing its first AI-assisted personalized tumor vaccine production line, with Beijing-based Likang Life Sciences set to complete a drug research and manufacturing center in the Beijing Economic and Technological Development Zone by October. The project, backed by a 110 million yuan investment, aims to address cancer, the nation's second-leading cause of death.
Mentioned
Related Signal
Adjacent reporting
- China’s first AI-powered cancer vaccine production line set to launch in Beijing
- Akeso To Boost Manufacturing Of Cancer Drug
- Scientists create “smart” DNA drug that targets cancer cells with extreme precision
- Moderna gets $50M investment for Ebola vaccine candidate
- New cancer tech sends chemo straight to tumors
- London startup to trial drug to prevent cancer therapy side-effect ‘cytokine storm’